BR0007862A - Method to increase the level of vitamin E in the plasma of a cat or dog, food product for cats or dogs, methods to prevent or treat a dog or cat suffering from a disorder, to maintain the optimization or reinforcement of an immune response to a challenge immune system in an animal, use of vitamin e, method of making a food product, and use of vitamin c - Google Patents
Method to increase the level of vitamin E in the plasma of a cat or dog, food product for cats or dogs, methods to prevent or treat a dog or cat suffering from a disorder, to maintain the optimization or reinforcement of an immune response to a challenge immune system in an animal, use of vitamin e, method of making a food product, and use of vitamin cInfo
- Publication number
- BR0007862A BR0007862A BR0007862-0A BR0007862A BR0007862A BR 0007862 A BR0007862 A BR 0007862A BR 0007862 A BR0007862 A BR 0007862A BR 0007862 A BR0007862 A BR 0007862A
- Authority
- BR
- Brazil
- Prior art keywords
- vitamin
- dog
- cat
- food product
- reinforcement
- Prior art date
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title abstract 8
- 241000282472 Canis lupus familiaris Species 0.000 title abstract 7
- 241000282326 Felis catus Species 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 7
- 235000013305 food Nutrition 0.000 title abstract 5
- 230000002787 reinforcement Effects 0.000 title abstract 5
- 229930003427 Vitamin E Natural products 0.000 title abstract 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 title abstract 4
- 235000019165 vitamin E Nutrition 0.000 title abstract 4
- 229940046009 vitamin E Drugs 0.000 title abstract 4
- 239000011709 vitamin E Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 229930003231 vitamin Natural products 0.000 title abstract 3
- 229940088594 vitamin Drugs 0.000 title abstract 3
- 235000013343 vitamin Nutrition 0.000 title abstract 3
- 239000011782 vitamin Substances 0.000 title abstract 3
- 150000003722 vitamin derivatives Chemical class 0.000 title abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 title abstract 2
- 230000028993 immune response Effects 0.000 title abstract 2
- 238000005457 optimization Methods 0.000 title abstract 2
- 229960005070 ascorbic acid Drugs 0.000 title 1
- 210000000987 immune system Anatomy 0.000 title 1
- 230000036542 oxidative stress Effects 0.000 abstract 4
- 241000824799 Canis lupus dingo Species 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Birds (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
MéTODO PARA AUMENTAR O NìVEL DE VITAMINA E NO PLASMA DE UM GATO OU CACHORRO, PRODUTO ALIMENTìCIO PARA GATOS OU CACHORROS, MéTODOS PARA PREVENIR OU TRATAR UM CACHORRO OU GATO SOFRENDO DE UM DISTúRBIO, PARA MANTER A OTIMIZAçãO OU REFORçO DE UMA RESPOSTA IMUNE A UM DESAFIO IMUNOLóGICO EM UM ANIMAL, USO DE VITAMINA E, MéTODO PARA FABRICAR UM PRODUTO ALIMENTìCIO, E, USO DE VITAMINA C". A presente invenção provê, dentre outros, um meio para superar o problema de estresse oxidativo no gato ou cachorro doméstico. é provido um método para aumentar o nível de vitamina E no plasma, o método compreendendo a etapa de administração ao referido gato ou cachorro, de uma quantidade de vitamina E suficiente para aumentar o nível de vitamina E no plasma. Também é provido o uso de vitamina C na fabricação de um produto alimentício para gato ou cachorro para a prevenção ou tratamento de um distúrbio, que tem um componente de estresse oxidativo. A presente invenção usa um coquetel antioxidantes para superar o problema de estresse oxidativo em um gato ou cachorro. Este coquetel pode ser usado para prevenir ou tratar um distúrbio que tem um componente de estresse oxidativo para manter, otimizar ou reforçar a resposta imunológica.METHOD FOR INCREASING THE LEVEL OF VITAMIN AND IN THE PLASMA OF A CAT OR DOG, FOOD PRODUCT FOR CATS OR DOGS, METHODS FOR PREVENTING OR TREATING A DOG OR CAT SUFFERING A DISTURBANCE, TO MAINTAIN THE OPTIMIZATION OF A REINFORCEMENT OF A REINFORCEMENT OF A REINFORCEMENT OF A REINFORCEMENT. IMMUNOLOGICAL IN AN ANIMAL, USE OF VITAMIN AND, METHOD FOR MANUFACTURING A FOOD PRODUCT, AND USE OF VITAMIN C ". The present invention provides, among others, a means to overcome the problem of oxidative stress in the domestic cat or dog. a method for increasing the level of vitamin E in the plasma, the method comprising the step of administering to the said cat or dog, an amount of vitamin E sufficient to increase the level of vitamin E in the plasma. in the manufacture of a cat or dog food product for the prevention or treatment of a disorder, which has an oxidative stress component. The present invention uses a coq uetel antioxidants to overcome the problem of oxidative stress in a cat or dog. This cocktail can be used to prevent or treat a disorder that has an oxidative stress component to maintain, optimize or boost the immune response.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9902051.3A GB9902051D0 (en) | 1999-01-29 | 1999-01-29 | Compositions and methods |
| GBGB9928549.6A GB9928549D0 (en) | 1999-12-02 | 1999-12-02 | Compositions and methods |
| PCT/GB2000/000270 WO2000044375A1 (en) | 1999-01-29 | 2000-01-31 | Antioxidant compositions and methods for companion animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0007862A true BR0007862A (en) | 2001-10-23 |
Family
ID=26315062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0007862-0A BR0007862A (en) | 1999-01-29 | 2000-01-31 | Method to increase the level of vitamin E in the plasma of a cat or dog, food product for cats or dogs, methods to prevent or treat a dog or cat suffering from a disorder, to maintain the optimization or reinforcement of an immune response to a challenge immune system in an animal, use of vitamin e, method of making a food product, and use of vitamin c |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1146870B1 (en) |
| JP (1) | JP4966450B2 (en) |
| CN (1) | CN1342073A (en) |
| AT (1) | ATE336998T1 (en) |
| AU (1) | AU766335C (en) |
| BR (1) | BR0007862A (en) |
| CA (1) | CA2360680C (en) |
| DE (1) | DE60030253T2 (en) |
| GB (1) | GB2366179B (en) |
| HU (1) | HUP0200075A3 (en) |
| MX (1) | MXPA01007661A (en) |
| NZ (2) | NZ527924A (en) |
| PL (1) | PL350187A1 (en) |
| WO (1) | WO2000044375A1 (en) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2367489B (en) * | 2000-07-31 | 2005-02-09 | Mars Inc | Use of antioxidants |
| IL146438A0 (en) * | 1999-05-27 | 2002-07-25 | Iams Company | Process and product for enhancing immune response in companion animal using a combination of antioxidants |
| BR0013879B1 (en) * | 1999-09-09 | 2013-07-23 | non-therapeutic and nutraceutical method to improve health, increase longevity or increase the quality of life of an older pet, and pet food | |
| US6996807B1 (en) * | 2000-02-01 | 2006-02-07 | Isogon Corporation | Consolidation and reduction of usage data |
| US8669282B2 (en) | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
| US20020115710A1 (en) * | 2000-10-31 | 2002-08-22 | Zicker Steven Curtis | Composition and method |
| CN1853496B (en) * | 2000-10-31 | 2011-11-02 | 高露洁-棕榄公司 | Composition and method |
| US20020076470A1 (en) | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
| AU2007216796B2 (en) * | 2000-10-31 | 2011-06-09 | Colgate-Palmolive Company | Composition and method |
| US8592479B2 (en) | 2000-10-31 | 2013-11-26 | Hill's Pet Nutrition, Inc. | Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals |
| JP2010142237A (en) * | 2000-10-31 | 2010-07-01 | Colgate Palmolive Co | Composition and method |
| GB0119052D0 (en) * | 2001-08-03 | 2001-09-26 | Mars Uk Ltd | Foodstuff |
| AU2002327517B2 (en) | 2001-08-21 | 2008-04-17 | Johnson & Johnson Consumer Companies, Inc. | Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| CN1522144A (en) * | 2002-01-31 | 2004-08-18 | 关西Tlo株式会社 | Compositions for preventing human cancer and method of preventing human cancer |
| GB0202258D0 (en) * | 2002-01-31 | 2002-03-20 | Dodson & Horrell Ltd | Annimal feed supplement |
| DE60238663D1 (en) † | 2002-04-05 | 2011-02-03 | Nestle Sa | Compositions and methods for improving lipid assimilation in pets |
| GB0218932D0 (en) * | 2002-08-14 | 2002-09-25 | Zoolife Internat Ltd | Composition for dietary enrichment |
| CA2510729C (en) * | 2002-12-20 | 2011-11-29 | Mars Uk Limited | Foodstuff profile for cats |
| ATE534384T1 (en) * | 2003-01-17 | 2011-12-15 | Vital Health Sciences Pty Ltd | COMPOUNDS WITH ANTI-PROLIFERATION PROPERTIES |
| WO2005006877A1 (en) * | 2003-07-03 | 2005-01-27 | Hill's Pet Nutrition, Inc. | Compositions and methods for decreasing age-related deterioration in metal activities in companion animals |
| RU2358440C2 (en) | 2003-07-07 | 2009-06-20 | Хилл`С Пет Ньютришн, Инк. | Composition for improved oxidising status of domestic animals |
| ITMI20032528A1 (en) * | 2003-12-19 | 2005-06-20 | Francesco Santangelo | USE OF CYSTINE OR CISTEIN FOR PREVENTION AND THE |
| WO2005099478A1 (en) * | 2004-04-16 | 2005-10-27 | Nestec S.A. | Method and compositions for reducing oxidative stress in an animal |
| CA2579032C (en) | 2004-09-02 | 2011-11-29 | Cosmo Oil Co., Ltd. | Use of an .delta.-amino acid as thymocyte growth agent |
| JP4814568B2 (en) * | 2004-09-02 | 2011-11-16 | コスモ石油株式会社 | Immune function improver |
| CN102784396B (en) | 2004-11-09 | 2015-07-29 | 希尔氏宠物营养品公司 | Antioxidant is used for the purposes of Gene regulation |
| BRPI0519642A8 (en) | 2004-12-29 | 2017-10-03 | Hill´S Pet Nutrition Inc | METHOD FOR INHIBITING A DECLINE IN LEARNING AND/OR MEMORY, APPROPRIATE KIT FOR ADMINISTERING ONE OR MORE ANTIOXIDANTS TO AN ANIMAL, MEDIA FOR TRANSMITTING INFORMATION, AND, USE OF A COMPOSITION |
| US8647660B2 (en) | 2004-12-29 | 2014-02-11 | Hill's Pet Nutrition, Inc. | Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health |
| AU2005324199A1 (en) * | 2005-01-05 | 2006-07-13 | Magd Ahmed Kotb Abdalla | Taurine synthesis, production and utility as a medicine |
| EP1874130A4 (en) * | 2005-04-19 | 2009-04-29 | Hills Pet Nutrition Inc | Methods and compositions for the prevention and treatment of kidney disease |
| MX2007015949A (en) | 2005-06-17 | 2008-03-07 | Vital Health Sciences Pty Ltd | A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof. |
| BRPI0613000A2 (en) | 2005-07-14 | 2012-12-04 | Hills Pet Nutrition Inc | method for increasing an animal's longevity, article of manufacture, kit, and means of communicating information about or instructions for administering to an old animal a composition |
| RU2377980C2 (en) | 2005-08-17 | 2010-01-10 | Хилл`С Пет Ньютришн, Инк. | Methods and compounds for kidney diseases prophylactics and treatment |
| JP2009522311A (en) † | 2005-12-29 | 2009-06-11 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | Methods for regulating intestinal flora in animals |
| JP2009532480A (en) * | 2006-04-04 | 2009-09-10 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | Compositions and methods for enhancing the antioxidant status of animals |
| WO2008099469A1 (en) * | 2007-02-14 | 2008-08-21 | Tohoku University | Composition and method for suppressing lipid peroxidation in erythrocytes |
| WO2008103956A1 (en) | 2007-02-22 | 2008-08-28 | Hill's Pet Nutrition, Inc. | Compositions and methods for promoting bone development |
| IL184575A0 (en) * | 2007-07-12 | 2008-01-20 | Lycored Ltd | Synergistic combinations for treating hypertension |
| EP2320752A1 (en) * | 2008-07-18 | 2011-05-18 | Hill's Pet Nutrition, Inc. | Method for enhancing the quality of life of a senior animal |
| EP2364098B1 (en) * | 2008-12-16 | 2016-10-12 | Hill's Pet Nutrition, Inc. | Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals |
| US20120270954A1 (en) * | 2009-10-30 | 2012-10-25 | Yuanlong Pan | Methods for maintaining eye health and ameliorating opthalmic maladies in canines |
| EP2531047A4 (en) | 2010-02-05 | 2014-03-19 | Phosphagenics Ltd | Carrier comprising non-neutralised tocopheryl phosphate |
| CA2794734C (en) | 2010-03-30 | 2017-12-12 | Phosphagenics Limited | Transdermal delivery patch |
| US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
| DE102011052687A1 (en) | 2011-08-12 | 2013-02-14 | Lohmann Animal Health Gmbh | Use of antioxidants |
| MY158177A (en) * | 2014-12-04 | 2016-09-06 | Univ Putra Malaysia | Antioxidant and/or antimicrobial composition based on palm oil |
| CN108601732A (en) | 2015-12-09 | 2018-09-28 | 磷肌酸有限公司 | pharmaceutical preparation |
| WO2018112512A1 (en) | 2016-12-21 | 2018-06-28 | Phosphagenics Limited | Process |
| US11690878B2 (en) | 2020-01-21 | 2023-07-04 | Lintbells Limited | Synergistic compositions |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3384545A (en) * | 1965-03-09 | 1968-05-21 | Hoffmann La Roche | Injectable aqueous emulsions of fat soluble vitamins |
| GB2042337A (en) * | 1979-02-28 | 1980-09-24 | Fox E | Pharmaceutical composition for arthritic conditions |
| JPS62195254A (en) * | 1986-02-19 | 1987-08-28 | Mitsubishi Gas Chem Co Inc | Feed |
| GB2185673B (en) * | 1986-01-08 | 1990-03-21 | Mitsubishi Gas Chemical Co | Palm leaf fodder |
| US5141755A (en) * | 1991-05-29 | 1992-08-25 | Weisman Eric H | Reduced animal product pet food composition |
| JPH0779712A (en) * | 1993-09-17 | 1995-03-28 | Sanei Gen F F I Inc | Preparation containing water-soluble hemicellulose |
| JP2696485B2 (en) * | 1994-07-07 | 1998-01-14 | 日本物産株式会社 | Extraction method of fish and shellfish algae extract containing large amount of mineral components |
| AT506U1 (en) * | 1994-11-22 | 1995-12-27 | Erber Erich Kg | FEEDING MATERIALS DRINKING WATER ADDED TO IMPROVE THE STRESS RESISTANCE AND IMMUNITY OF FARM ANIMALS |
| SE506191C2 (en) * | 1996-03-27 | 1997-11-17 | Astacarotene Ab | Means and ways to increase the production of / in mammals |
| EP0834262A4 (en) * | 1996-04-10 | 1999-03-24 | Nichimo Kk | Substance containing health-promoting component and process for the production thereof |
| ZA965149B (en) * | 1996-06-18 | 1997-01-23 | Henry John Davis | Vitamin and nutrient supplement compositions |
| JPH10175866A (en) * | 1996-12-18 | 1998-06-30 | Showa Denko Kk | Stress reaction relaxing agent for animal and stress reaction relaxation |
| AU770392B2 (en) * | 1998-07-07 | 2004-02-19 | Coastside Bio Resources | Companion animal therapeutic treat |
-
2000
- 2000-01-29 NZ NZ527924A patent/NZ527924A/en not_active IP Right Cessation
- 2000-01-31 AU AU23042/00A patent/AU766335C/en not_active Expired
- 2000-01-31 GB GB0118809A patent/GB2366179B/en not_active Expired - Lifetime
- 2000-01-31 MX MXPA01007661A patent/MXPA01007661A/en unknown
- 2000-01-31 AT AT00901737T patent/ATE336998T1/en not_active IP Right Cessation
- 2000-01-31 EP EP00901737A patent/EP1146870B1/en not_active Expired - Lifetime
- 2000-01-31 BR BR0007862-0A patent/BR0007862A/en not_active IP Right Cessation
- 2000-01-31 CA CA2360680A patent/CA2360680C/en not_active Expired - Lifetime
- 2000-01-31 NZ NZ513131A patent/NZ513131A/en not_active IP Right Cessation
- 2000-01-31 HU HU0200075A patent/HUP0200075A3/en unknown
- 2000-01-31 PL PL00350187A patent/PL350187A1/en not_active Application Discontinuation
- 2000-01-31 CN CN00804371A patent/CN1342073A/en active Pending
- 2000-01-31 DE DE60030253T patent/DE60030253T2/en not_active Expired - Lifetime
- 2000-01-31 WO PCT/GB2000/000270 patent/WO2000044375A1/en active IP Right Grant
- 2000-01-31 JP JP2000595678A patent/JP4966450B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0200075A3 (en) | 2005-05-30 |
| HUP0200075A2 (en) | 2002-05-29 |
| EP1146870B1 (en) | 2006-08-23 |
| MXPA01007661A (en) | 2002-07-02 |
| PL350187A1 (en) | 2002-11-18 |
| AU2304200A (en) | 2000-08-18 |
| NZ513131A (en) | 2003-11-28 |
| DE60030253T2 (en) | 2007-07-19 |
| ATE336998T1 (en) | 2006-09-15 |
| NZ527924A (en) | 2005-01-28 |
| EP1146870A1 (en) | 2001-10-24 |
| DE60030253D1 (en) | 2006-10-05 |
| WO2000044375A1 (en) | 2000-08-03 |
| CN1342073A (en) | 2002-03-27 |
| GB2366179B (en) | 2003-04-16 |
| AU766335B2 (en) | 2003-10-16 |
| AU766335C (en) | 2004-06-03 |
| CA2360680A1 (en) | 2000-08-03 |
| GB0118809D0 (en) | 2001-09-26 |
| GB2366179A (en) | 2002-03-06 |
| CA2360680C (en) | 2010-04-13 |
| JP2002535364A (en) | 2002-10-22 |
| JP4966450B2 (en) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0007862A (en) | Method to increase the level of vitamin E in the plasma of a cat or dog, food product for cats or dogs, methods to prevent or treat a dog or cat suffering from a disorder, to maintain the optimization or reinforcement of an immune response to a challenge immune system in an animal, use of vitamin e, method of making a food product, and use of vitamin c | |
| BR0013879A (en) | Improvement of the health condition of pets of old age | |
| DK1392131T3 (en) | Skin Diet Feeds for Pets | |
| BR0214962A (en) | Composition for treating neurocerebrovascular disorders | |
| FI971083A0 (en) | Substance to increase production in animal husbandry and production in the poultry industry | |
| DE60021266D1 (en) | USES OF COMPOSITIONS FOR TREATING OR PREVENTING SLEEP DISORDERS WITH VERY LOW-DOSED CYCLOBENZAPRINE | |
| FI934891A (en) | COMBINATION OF CALCIUM AND VITAMIN D-SUPPLEMENT | |
| BR0113128A (en) | Method of treating a ras-mediated proliferative disorder in a mammal, pharmaceutical composition, and kit | |
| BR0209567A (en) | Process, systems and equipment to influence meeting the needs and specific volume of soil and vegetation | |
| BR0111601A (en) | Method for the treatment of cardiovascular disease | |
| BR0211344A (en) | Animal feed with low puff concentration | |
| WO2008016659A3 (en) | Agents for treating neurodegenerative diseases | |
| WO2005007652A3 (en) | Substituted quinolin-4-ylamine analogues | |
| SE0003544L (en) | Process for the preparation of an absorbent sanitary article comprising lactic acid producing bacteria as well as such | |
| BR0116606A (en) | methods and compositions for detecting compounds that modulate inflammatory responses | |
| EP1254260A4 (en) | Methods for diagnosing and treating heart disease | |
| BR0311899A (en) | Composition, methods of repelling arachnids, treating or preventing chicken mites or northern bird mites in chickens, chickens and young chicks and attracting arachnids, and solution. | |
| BR0312929A (en) | Use of a compound, and methods of treating, preventing or alleviating a disease, disorder or condition of a living animal body, and the age-related macular degeneration of a living animal body | |
| WO2005086968A3 (en) | Substituted 5,12-diaza-benzoanthracene analogues | |
| WO2002062205A3 (en) | Methods for diagnosing and treating heart disease | |
| MX2021015590A (en) | Methods and compositions with renal benefits for felines. | |
| DK1043028T3 (en) | Phytase for the prevention or treatment of mastitis | |
| WO2006138385A3 (en) | Use of phenserine and analogs to treat behavioral problems and improve trainability | |
| MY135972A (en) | Egg anti-inflammatory composition and method of treating and preventing inflammation | |
| BR0214006A (en) | Composition, and methods for controlling the rate of hair growth in a dog or cat, and for preventing or treating unsatisfactory hair growth or alopecia in animals. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/07 (2006.01), A23K 20/142 (2016.01), A23K |